We would like to introduce Dr. Yvette Drew. Dr Drew has a joint faculty appointment at the rank of Associate Professor with OBGYN and the Department of Medicine, Division of Medical Oncology. This position was as a result of the faculty renewal program run by the Faculty of Medicine.
Dr Yvette Drew previously worked as Senior Lecturer and Consultant in Medical Oncology at the Northern Centre for Cancer Care (NCCC) and the Clinical and Translational Research Institute, Newcastle University since 2014. She was regional gynae medical oncology trials lead, deputy lead for the Newcastle Experimental Cancer Medicines centre (phase 1 unit) and co-lead of the gynae-onc translational team.
Dr Drew undertook specialist medical oncology training at the Beatson West of Scotland Cancer Centre, Glasgow and the NCCC. During this time she was awarded a CRUK-funded PhD fellowship investigating the role of PARP inhibitors in Homologous Recombination deficient ovarian cancer. During her PhD she won a Merit award for her research from the American Society of Clinical Oncology (ASCO) and was awarded the Medical Sciences Doctoral Prize (Newcastle university, 2013). She has played a key role in both the pre-clinical and clinical development of the PARP inhibitor rucaparib in ovarian cancer. In the UK she has also led on trials as national CI from first-in-human phase 1 to later phase 3 clinical trials and been active as a member of both the NCRI Ovarian and Endometrial clinical studies sub-groups. Research interests include the targeting DNA repair pathways as treatment for gynaecological cancers and PARP inhibitor resistance.
Please join us in welcoming her to the Department.